Safety and Tolerability of Suprachoroidal Axitinib, CLS-AX, for Neovascular AMD; Phase 1/2a Open-Label, Dose-Escalation Trial
-
Published:2024-07
Issue:
Volume:
Page:100586
-
ISSN:2666-9145
-
Container-title:Ophthalmology Science
-
language:en
-
Short-container-title:Ophthalmology Science
Author:
Barakat Mark R.,
Brown David,
Hu Allen,
Khurana Rahul N.,
Marcus Dennis,
Pearlman Joel,
Wykoff CharlesORCID,
Kapik BarryORCID,
Ciulla ThomasORCID